r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

SS

Steven H. Stein

Insider · CMO & Head of Late-Stage Dev. · INCY

Steven H. Stein files insider transactions with the SEC as a cmo & head of late-stage dev. of Incyte (INCY). We hold 3 disclosed purchases and sales filed since 19 July 2016, 2 of them in the last 90 days.

  • Files forINCY
  • Disclosed buys and sells3 in all, 2 in the last 90 days
  • Last disclosure20 July 2026

Positions held

4 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 15 July 2016 — 16 July 2026CMO & Head of Late-Stage Dev. · Incyte (INCY)158 Form 4 lines · source: SEC Form 4
  • Filed 17 June 2024 — 17 June 2024Director · Repare Therapeutics (RPTX)1 Form 4 line · source: SEC Form 4
  • Filed 17 October 2022 — 14 February 2024Director · Theseus Pharmaceuticals (THRX)4 Form 4 lines · source: SEC Form 4
  • Filed 3 January 2017 — 21 June 2022Director · Kura Oncology (KURA)8 Form 4 lines · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.